Advaxis, Inc

(NASDAQ:ADXS)

Latest On Advaxis, Inc (ADXS):

Date/Time Type Description Signal Details
2023-03-03 17:46 ESTNewsAyala Pharma to continue Phase 2/3 Ringside study in desmoid tumorsN/A
2023-02-10 10:00 ESTNewsAdvaxis GAAP EPS of -$8.46, revenue of $0.25MN/A
2023-01-18 16:01 ESTNewsAyala sees last day of trading as merger with Advaxis takes placeN/A
2022-10-19 21:34 ESTNewsAyala rises 16% on all-stock merger with Advaxis to focus on cancer drugsN/A
2022-09-13 06:01 ESTNewsAdvaxis GAAP EPS of -$3.83N/A
2022-06-04 13:46 ESTNewsAdvaxis to implement one-for-80 reverse splitN/A
2022-03-18 10:35 ESTNewsAdvaxis GAAP EPS of $0.00N/A
2022-02-14 23:16 ESTNewsAdvaxis  GAAP EPS of -$0.14 beats by $0.03, revenue of $3.24M beats by $0.25MN/A
2022-01-28 19:47 ESTNewsAdvaxis prices $5M in convertible redeemable preferred stock offeringN/A
2021-12-23 07:17 ESTNewsAdvaxis to start trading on OTCQX on Dec 23N/A
2021-12-17 17:32 ESTNewsAdvaxis wins shareholder approval for Biosight mergerN/A
2021-09-10 15:49 ESTNewsAdvaxis EPS beats by $0.02N/A
2021-09-10 15:46 ESTNewsAdvaxis reaches five month high after better than expected financialsN/A
2021-07-20 17:47 ESTNewsAdvaxis  EPS beats by $0.01N/A
2021-07-20 17:33 ESTNewsAdvaxis and Biosight announce merger deal to create oncology focused public companyN/A
2021-07-20 17:25 ESTNewsAdvaxis initiates early-stage ADXS-504 prostate cancer studyN/A
2021-04-26 15:18 ESTNewsAdvaxis shares rise after receiving milestone payment under ADXS-HER2 licensing dealN/A
2021-04-12 15:17 ESTNewsAdvaxis proposes $20M registered direct offeringN/A
2021-04-05 22:03 ESTNewsAdvaxis to fund earl-stage ADXS-504 study for prostate cancerN/A
2021-03-18 08:02 ESTFinancialsCompany financials have been released.Neutral
2021-03-16 11:01 ESTNewsAdvaxis reports FQ1 resultsN/A
2021-01-26 04:01 ESTNewsAdvaxis gives business update and provides 2020 FY resultsN/A
2021-01-24 07:02 ESTFinancialsCompany financials have been released.Neutral
2021-01-19 23:31 ESTNewsAdvaxis rallies on first milestone payment under ADXS31-164 licensing agreementN/A
2020-12-13 03:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 12:36 ESTNewsAdvaxis under pressure after hours; readies underwritten public offeringN/A
2020-11-24 12:32 ESTNewsAdvaxis plunges after announcing $8M public offeringN/A
2020-11-01 16:51 ESTFinancialsCompany financials have been released.Neutral
2020-10-26 10:02 ESTNewsAdvaxis down 12% despite ADXS-503 shows sustained tumor control in mid-stage lung cancer trialN/A
2020-09-26 04:03 ESTFinancialsCompany financials have been released.Neutral
2020-09-25 10:49 ESTNewsAdvaxis on go with early-stage study with ADXS-504 in prostate cancerN/A
2020-09-15 04:03 ESTFinancialsCompany financials have been released.Neutral
2020-09-12 04:02 ESTFinancialsCompany financials have been released.Neutral
2020-09-10 16:48 ESTNewsAdvaxis EPS beats by $0.06N/A
2020-09-04 19:54 ESTNewsAdvaxis (ADXS) Investor Presentation - SlideshowN/A
2020-09-04 19:48 ESTNewsAdvaxis CFO resigns; CEO to serve interim CFON/A
2020-08-04 06:04 ESTNewsAdvaxis inks $20M stock purchase agreement with Lincoln Park CapitalN/A
2020-07-31 00:03 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:06 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 04:02 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:51 ESTNewsAdvaxis  EPS beats by $0.05N/A
2020-06-12 05:47 ESTNewsAdvaxis, Inc. (ADXS) CEO Ken Berlin on Q2 2020 Results - Earnings Call TranscriptN/A
2020-05-03 08:02 ESTFinancialsCompany financials have been released.Neutral
2020-04-10 16:07 ESTNewsAdvaxis teams up with Personalis for ADXS-503 program; shares up 13% premarketN/A
2020-04-10 16:04 ESTNewsAdvaxis' ADXS-PSA extends survival in prostate cancer patientsN/A
2020-04-10 15:33 ESTNewsAdvaxis EPS beats by $0.04N/A
2020-04-09 04:02 ESTFinancialsCompany financials have been released.Neutral
2020-04-08 04:02 ESTFinancialsCompany financials have been released.Neutral
2020-04-08 00:02 ESTFinancialsCompany financials have been released.Neutral

About Advaxis, Inc (ADXS):

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Princeton, New Jersey.

ADXS Quotes by TradingView

See Advanced Chart

General

  • Name Advaxis, Inc
  • Symbol ADXS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 17
  • Last Split Factor1:15
  • Last Split Date2019-03-29
  • Fiscal Year EndOctober
  • IPO Date2005-07-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.advaxis.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 32.28
  • Price/Book (Most Recent Quarter) 2.77
  • Enterprise Value Revenue 41.09
View More

Financials

  • Most Recent Quarter 2021-01-31
  • Operating Margin -9353%
  • Return on Assets -35%
  • Return on Equity -76%
  • Revenue 253000
  • Earnings Per Share -$4.09
  • Revenue Per Share $0
  • Gross Profit 253000
  • Quarterly Earnings Growth -100%
View More

Highlights

  • Market Capitalization 100.11 million
  • EBITDA -26629000
  • PE Ratio -1.99
  • Analyst Target Price $5
  • Book Value Per Share $0.39
View More

Share Statistics

  • Shares Outstanding 119.47 million
  • Shares Float 105.83 million
  • % Held by Insiders 9%
  • % Held by Institutions 17.72%
  • Shares Short 4.69 million
  • Shares Short Prior Month 5.35 million
  • Short Ratio 0.29
  • Short % of Float 4%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 2.88
  • 52 Week High $1.57
  • 52 Week Low $0.27
  • 50 Day Moving Average 0.91
  • 200 Day Moving Average 0.55
View More

Dividends

  • Dividend Date 2019-03-29
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Advaxis, Inc (ADXS) Dividend Calendar:

ADXS's last dividend payment was made to shareholders on March 29, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Advaxis, Inc (ADXS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2021-01-312021-03-11$1.62 million-$0.05
2020-10-312021-01-19$N/A-$0.09
2020-07-312020-09-10$N/A-$0.09-$0.1540%
2020-04-302020-06-11$N/A-$0.10-$0.1533.33%
2020-01-312020-03-13$3000-$0.15-$0.1921.05%
2019-10-312019-12-20$1000-$0.15-$0.3151.61%
2019-07-312019-09-09$6000-$1.00-$1.3224.24%
2019-04-302019-06-10$1.19 million-$1.59-$1.57-1.27%
2019-01-312019-03-12$19.69 million$2.70-$3.75172%
2018-10-312019-01-10$1.13 million-$4.35-$1.80-141.67%
2018-07-312018-09-10$1.13 million-$4.05-$3.90-3.85%
2018-04-302018-06-07$1.75 million-$4.05-$6.4537.21%
2018-01-312018-03-12$2.06 million-$7.35-$8.2510.91%
2017-10-312017-12-20$1.76 million-$8.55-$8.05-6.21%
2017-07-312017-09-11$3.05 million-$12.00-$8.30-44.58%
2017-04-302017-06-06$3.43 million-$7.65-$7.15-6.99%
2017-01-312017-03-10$3.79 million-$6.45-$7.6515.69%
2016-10-312017-01-09$3.75 million-$8.40-$8.03-4.67%
2016-07-312016-09-08$N/A-$7.20-$8.3313.51%
2016-04-302016-06-08$-250000-$6.75-$8.1316.97%
2016-01-312016-02-26$250000-$8.85-$6.60-34.09%
2015-10-312016-01-08$N/A-$0.38-$0.429.52%
2015-07-312015-09-11$N/A-$0.44-$0.40-10%
2015-04-302015-06-15$N/A-$0.52-$0.28-85.71%
2015-01-312015-03-13$N/A-$0.33-$0.28-17.86%
2014-10-312015-01-06$1000000-$0.15-$0.3050%
2014-07-312014-09-09$-1000000-$0.30-$0.25-20%
2014-04-302014-06-10$1000000-$2.25-$3.9042.31%
2014-01-312014-03-17$N/A-$5.55-$3.60-54.17%
2013-10-312014-01-29$N/A-$14.55
2013-07-312013-10-02$N/A-$5.59
2013-04-302013-07-03$N/A-$19.37
2013-01-312013-04-03$N/A-$24.80
2012-10-312013-01-02$N/A-$12.72
2012-07-312012-10-03$N/A-$17.78
2012-04-302012-06-27$N/A-$17.00
2012-01-312012-03-28$N/A-$32.46
2011-10-312011-12-28$N/A-$22.96
2011-07-312011-09-28$N/A$18.61
2011-04-302011-06-14$N/A-$86.25-$37.50-130%
2011-01-312011-03-30$N/A-$2.11
2010-07-312010-09-14$177000$18.75-$37.50150%
2010-04-302010-06-03$87000-$131.25-$18.75-600%
2010-01-312010-03-19$N/A-$56.25-$18.75-200%
2009-10-312009-12-30$35000$22.63
2009-07-312009-07-31$N/A$2.80
2009-04-302009-04-30$N/A-$13.24
2009-01-312009-01-31$N/A$3.10
2008-07-312008-07-31-$21.19
2008-04-302008-04-30-$27.83
2008-01-312008-01-31-$24.34
2007-07-312007-07-31$38.28
2007-04-302007-04-30-$134.49
2007-01-312007-01-31-$1.69
2006-10-312006-10-31-$181.92
2006-07-312006-07-31-$32.95
2006-04-302006-04-30-$64.04
2006-01-312006-01-31-$22.75
2005-10-312005-10-31-$18.75
2005-07-312005-07-31-$19.52

Advaxis, Inc (ADXS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Advaxis, Inc (ADXS) Chart:

Advaxis, Inc (ADXS) News:

Below you will find a list of latest news for Advaxis, Inc (ADXS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Advaxis, Inc (ADXS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Advaxis, Inc (ADXS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220011908/0001493152-20-011908-index.htm
2019-07-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1100397/000000000019010864/0000000000-19-010864-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000090266419000922/0000902664-19-000922-index.htm
2019-04-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000090266419001893/0000902664-19-001893-index.htm
2020-01-21SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000090266420000310/0000902664-20-000310-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000103738920000093/0001037389-20-000093-index.htm
2018-09-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000110465918056836/0001104659-18-056836-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000110465919008568/0001104659-19-008568-index.htm
2020-01-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000110465920008419/0001104659-20-008419-index.htm
2020-08-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000110465920089611/0001104659-20-089611-index.htm
2019-02-14PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1100397/000114036119003113/0001140361-19-003113-index.htm
2018-12-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000119312518360947/0001193125-18-360947-index.htm
2019-04-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000119312519101677/0001193125-19-101677-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000119312520038367/0001193125-20-038367-index.htm
2018-10-1825-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1100397/000135445718000420/0001354457-18-000420-index.htm
2019-07-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000138713119005574/0001387131-19-005574-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000138713120001532/0001387131-20-001532-index.htm
2018-09-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1100397/000149315218013055/0001493152-18-013055-index.htm
2018-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315218013056/0001493152-18-013056-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315218013098/0001493152-18-013098-index.htm
2018-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218013213/0001493152-18-013213-index.htm
2018-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315218014888/0001493152-18-014888-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015218/0001493152-18-015218-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015359/0001493152-18-015359-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015360/0001493152-18-015360-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015361/0001493152-18-015361-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015362/0001493152-18-015362-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015363/0001493152-18-015363-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015364/0001493152-18-015364-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015365/0001493152-18-015365-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015366/0001493152-18-015366-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218015367/0001493152-18-015367-index.htm
2018-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315218017447/0001493152-18-017447-index.htm
2018-12-28PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1100397/000149315218018060/0001493152-18-018060-index.htm
2019-01-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1100397/000149315219000489/0001493152-19-000489-index.htm
2019-01-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219000490/0001493152-19-000490-index.htm
2019-01-14DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1100397/000149315219000615/0001493152-19-000615-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219000851/0001493152-19-000851-index.htm
2019-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219001515/0001493152-19-001515-index.htm
2019-02-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219002409/0001493152-19-002409-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219002751/0001493152-19-002751-index.htm
2019-03-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1100397/000149315219003181/0001493152-19-003181-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219003193/0001493152-19-003193-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219003298/0001493152-19-003298-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219003429/0001493152-19-003429-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219004231/0001493152-19-004231-index.htm
2019-04-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1100397/000149315219004750/0001493152-19-004750-index.htm
2019-04-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1100397/000149315219004851/0001493152-19-004851-index.htm
2019-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219004957/0001493152-19-004957-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219005007/0001493152-19-005007-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219005083/0001493152-19-005083-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219005147/0001493152-19-005147-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219005148/0001493152-19-005148-index.htm
2019-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219005172/0001493152-19-005172-index.htm
2019-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219005279/0001493152-19-005279-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219006924/0001493152-19-006924-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219007226/0001493152-19-007226-index.htm
2019-06-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1100397/000149315219008929/0001493152-19-008929-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219008958/0001493152-19-008958-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219009812/0001493152-19-009812-index.htm
2019-07-02S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1100397/000149315219010182/0001493152-19-010182-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219010617/0001493152-19-010617-index.htm
2019-07-17S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1100397/000149315219010710/0001493152-19-010710-index.htm
2019-07-17FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219010715/0001493152-19-010715-index.htm
2019-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1100397/000149315219010811/0001493152-19-010811-index.htm
2019-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1100397/000149315219010813/0001493152-19-010813-index.htm
2019-07-22S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1100397/000149315219010915/0001493152-19-010915-index.htm
2019-07-24424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1100397/000149315219011036/0001493152-19-011036-index.htm
2019-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219011146/0001493152-19-011146-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219011414/0001493152-19-011414-index.htm
2019-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219013270/0001493152-19-013270-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219013811/0001493152-19-013811-index.htm
2019-09-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1100397/000149315219013861/0001493152-19-013861-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219013867/0001493152-19-013867-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219014099/0001493152-19-014099-index.htm
2019-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219015081/0001493152-19-015081-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219015930/0001493152-19-015930-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219016004/0001493152-19-016004-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219016005/0001493152-19-016005-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219016006/0001493152-19-016006-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219016007/0001493152-19-016007-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219016008/0001493152-19-016008-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219016009/0001493152-19-016009-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219016010/0001493152-19-016010-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315219016011/0001493152-19-016011-index.htm
2019-12-2010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1100397/000149315219019523/0001493152-19-019523-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315219019533/0001493152-19-019533-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220000306/0001493152-20-000306-index.htm
2020-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220000664/0001493152-20-000664-index.htm
2020-01-2110-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1100397/000149315220000826/0001493152-20-000826-index.htm
2020-01-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1100397/000149315220000864/0001493152-20-000864-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220000983/0001493152-20-000983-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220002212/0001493152-20-002212-index.htm
2020-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220002491/0001493152-20-002491-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220002783/0001493152-20-002783-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220003076/0001493152-20-003076-index.htm
2020-02-2810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1100397/000149315220003138/0001493152-20-003138-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220003894/0001493152-20-003894-index.htm
2020-03-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1100397/000149315220003900/0001493152-20-003900-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220004065/0001493152-20-004065-index.htm
2020-03-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1100397/000149315220004430/0001493152-20-004430-index.htm
2020-03-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220004431/0001493152-20-004431-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220006182/0001493152-20-006182-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220006740/0001493152-20-006740-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220007724/0001493152-20-007724-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220007725/0001493152-20-007725-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220007726/0001493152-20-007726-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220007727/0001493152-20-007727-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220007728/0001493152-20-007728-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220007729/0001493152-20-007729-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220007730/0001493152-20-007730-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220007732/0001493152-20-007732-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220007735/0001493152-20-007735-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220008067/0001493152-20-008067-index.htm
2020-05-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1100397/000149315220008069/0001493152-20-008069-index.htm
2020-06-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1100397/000149315220010996/0001493152-20-010996-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1100397/000149315220011908/0001493152-20-011908-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220014443/0001493152-20-014443-index.htm
2020-08-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1100397/000149315220014444/0001493152-20-014444-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220017308/0001493152-20-017308-index.htm
2020-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220017557/0001493152-20-017557-index.htm
2020-09-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1100397/000149315220017558/0001493152-20-017558-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220018509/0001493152-20-018509-index.htm
2020-09-298-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1100397/000149315220018511/0001493152-20-018511-index.htm
2020-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220019118/0001493152-20-019118-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1100397/000149315220019578/0001493152-20-019578-index.htm
2019-04-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000153561019000075/0001535610-19-000075-index.htm
2020-01-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1100397/000153561020000014/0001535610-20-000014-index.htm
2019-07-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1100397/999999999519001661/9999999995-19-001661-index.htm

Advaxis, Inc (ADXS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Advaxis, Inc (ADXS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 9%
Institutional Ownership: 1772%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-04-09Molly HendersonExecutive Vice President & CFOBuy100.003.85385.00100.00https://www.sec.gov/Archives/edgar/data/1100397/000149315219005083/0001493152-19-005083-index.htm
2020-03-13RONI APPELDirectorSell2,401.000.551,320.5510,476.00https://www.sec.gov/Archives/edgar/data/1100397/000149315220004065/0001493152-20-004065-index.htm
2019-04-08Kenneth A BerlinPresident & CEOBuy1,100.003.784,152.501,100.00https://www.sec.gov/Archives/edgar/data/1100397/000149315219005007/0001493152-19-005007-index.htm
2020-03-12RONI APPELDirectorSell200.000.58116.0012,877.00https://www.sec.gov/Archives/edgar/data/1100397/000149315220004065/0001493152-20-004065-index.htm
2020-03-11RONI APPELDirectorSell399.000.67267.3313,077.00https://www.sec.gov/Archives/edgar/data/1100397/000149315220004065/0001493152-20-004065-index.htm
2019-04-10RONI APPELDirectorBuy3,000.003.8011,391.0013,476.00https://www.sec.gov/Archives/edgar/data/1100397/000149315219005148/0001493152-19-005148-index.htm
2018-09-11RONI APPELDirectorBuy33,333.001.2039,999.60157,143.00https://www.sec.gov/Archives/edgar/data/1100397/000149315218013213/0001493152-18-013213-index.htm
2019-04-08Kenneth A BerlinPresident & CEOBuy2,100.003.787,935.902,100.00https://www.sec.gov/Archives/edgar/data/1100397/000149315219005007/0001493152-19-005007-index.htm
2018-11-05ROBERT PETITChief Scientific OfficerSell3,963.000.582,298.54231,206.00https://www.sec.gov/Archives/edgar/data/1100397/000149315218015360/0001493152-18-015360-index.htm
2018-11-02ROBERT PETITChief Scientific OfficerSell8,491.000.564,754.96235,169.00https://www.sec.gov/Archives/edgar/data/1100397/000149315218015218/0001493152-18-015218-index.htm
2019-04-09Molly HendersonExecutive Vice President & CFOBuy2,900.003.8611,193.712,900.00https://www.sec.gov/Archives/edgar/data/1100397/000149315219005083/0001493152-19-005083-index.htm
2019-04-11Andres GutierrezExecutive Vice President & CMOBuy3,750.003.7113,928.253,750.00https://www.sec.gov/Archives/edgar/data/1100397/000149315219005172/0001493152-19-005172-index.htm
2019-04-11Molly HendersonExecutive Vice President & CFOBuy2,500.003.689,199.755,833.00https://www.sec.gov/Archives/edgar/data/1100397/000149315219005147/0001493152-19-005147-index.htm
2019-04-08Kenneth A BerlinPresident & CEOBuy800.003.783,024.00800.00https://www.sec.gov/Archives/edgar/data/1100397/000149315219005007/0001493152-19-005007-index.htm